Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis. Prosperini L, Giannì C, Barletta V, Mancinelli C, Fubelli F, Borriello G, Pozzilli C J Neurol Sci. 2012 Sep 21. PMID: 23006974. Abstract CommentRecommendBookmarkWatch